- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens ; volume:15 ; number:1 ; day:27 ; month:8 ; year:2024 ; pages:1-15 ; date:12.2024
Nature Communications ; 15, Heft 1 (27.8.2024), 1-15, 12.2024
- Urheber
-
Nuqui, Xandra
Casalino, Lorenzo
Zhou, Ling
Shehata, Mohamed
Wang, Albert
Tse, Alexandra L.
Ojha, Anupam A.
Kearns, Fiona L.
Rosenfeld, Mia A.
Miller, Emily Happy
Acreman, Cory M.
Ahn, Surl-Hee
Chandran, Kartik
McLellan, Jason S.
Amaro, Rommie E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-50976-9
- URN
-
urn:nbn:de:101:1-2411130739123.574169804339
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nuqui, Xandra
- Casalino, Lorenzo
- Zhou, Ling
- Shehata, Mohamed
- Wang, Albert
- Tse, Alexandra L.
- Ojha, Anupam A.
- Kearns, Fiona L.
- Rosenfeld, Mia A.
- Miller, Emily Happy
- Acreman, Cory M.
- Ahn, Surl-Hee
- Chandran, Kartik
- McLellan, Jason S.
- Amaro, Rommie E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens
Stabilizing the closed SARS-CoV-2 spike trimer
An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection